KD Pharma Group specializes in a wide array of Contract Development and Manufacturing Organization (CDMO) services, focusing on pharmaceutical and nutraceutical solutions. The company leverages advanced technologies in extraction, purification, and synthesis to create high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Notably, KD Pharma employs supercritical fluid chromatography for fatty acid separation and has developed patented lipid purification methods, enhancing their ability to deliver tailored solutions for complex formulations. Their expertise extends to the production of bioactive lipids, particularly omega-3s, which are integral to their pharmaceutical and nutritional offerings.

In addition to their capabilities in lipids, KD Pharma Group is recognized for its innovative approaches in developing small molecules and finished dosage forms, including softgels and liquid health solutions. The company emphasizes a vertically integrated model that allows for flexibility and agility in meeting customer needs. Their commitment to sustainability is evident in their use of natural resources and adherence to stringent global standards, ensuring minimal environmental impact while maintaining high quality and traceability in their products. This comprehensive technological foundation positions KD Pharma as a leader in the industry, dedicated to advancing health solutions through collaboration and innovation.

Switzerland

The KD Pharma Group is a CDMO that develops products in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer of API for Omega-3 pharmaceuticals and has built a similar market-leading position in Omega-3 nutraceuticals, formulation and encapsulation services, with over 500 employees and a presence in the UK, Norway, Germany, Switzerland and the US. The KD Pharma Group employs state-of-the-art technology which is protected by numerous patents.

KD Pharma Group

Company Details